Home / In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFRHER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFRHER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models Debasis Das & Lingzhi Xie & Jingbing Wang & Jingli Shi & Jian Hong ★ 5.0 · 120 reads Sign in to save this Request CodeZLIB.IO18509663 Published2022 Pages1 LanguageUnknown
